Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Buy Evercore Partners Inc. (EVR): Financial Engines Inc (FNGN), Cohen & Steers, Inc. (CNS)

Page 1 of 2

Is Evercore Partners Inc. (NYSE:EVR) the right pick for your portfolio? The smart money is in an optimistic mood. The number of bullish hedge fund positions went up by 1 recently.

Evercore Partners Inc. (NYSE:EVR)

In today’s marketplace, there are many methods investors can use to track publicly traded companies. Two of the most underrated are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top investment managers can outperform the market by a healthy margin (see just how much).

Just as important, positive insider trading activity is a second way to break down the financial markets. As the old adage goes: there are a variety of reasons for a corporate insider to cut shares of his or her company, but just one, very clear reason why they would initiate a purchase. Several empirical studies have demonstrated the valuable potential of this strategy if “monkeys” understand what to do (learn more here).

Now, let’s take a look at the latest action surrounding Evercore Partners Inc. (NYSE:EVR).

How are hedge funds trading Evercore Partners Inc. (NYSE:EVR)?

In preparation for this year, a total of 8 of the hedge funds we track held long positions in this stock, a change of 14% from the third quarter. With hedge funds’ sentiment swirling, there exists a few key hedge fund managers who were increasing their stakes significantly.

When looking at the hedgies we track, Citadel Investment Group, managed by Ken Griffin, holds the largest position in Evercore Partners Inc. (NYSE:EVR). Citadel Investment Group has a $56 million position in the stock, comprising 0.1% of its 13F portfolio. Sitting at the No. 2 spot is Andrew Sandler of Sandler Capital Management, with a $11 million position; 0.6% of its 13F portfolio is allocated to the company. Other hedge funds that are bullish include Chuck Royce’s Royce & Associates, Israel Englander’s Millennium Management and Steven Cohen’s SAC Capital Advisors.

As one would reasonably expect, key hedge funds were breaking ground themselves. Sandler Capital Management, managed by Andrew Sandler, assembled the most outsized position in Evercore Partners Inc. (NYSE:EVR). Sandler Capital Management had 11 million invested in the company at the end of the quarter. Glenn Russell Dubin’s Highbridge Capital Management also made a less than $1 million investment in the stock during the quarter. The only other fund with a brand new EVR position is David Costen Haley’s HBK Investments.

What have insiders been doing with Evercore Partners Inc. (NYSE:EVR)?

Insider buying is particularly usable when the company in question has seen transactions within the past six months. Over the last half-year time frame, Evercore Partners Inc. (NYSE:EVR) has seen zero unique insiders buying, and 5 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Evercore Partners Inc. (NYSE:EVR). These stocks are Financial Engines Inc (NASDAQ:FNGN), Cohen & Steers, Inc. (NYSE:CNS), Virtus Investment Partners Inc (NASDAQ:VRTS), Gamco Investors Inc. (NYSE:GBL), and WisdomTree Investments, Inc. (NASDAQ:WETF). All of these stocks are in the asset management industry and their market caps match EVR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!